Is Rising Biosciences Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Rising Biosciences Inc (RBII) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Rising Biosciences Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Rising Biosciences Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Rising Biosciences Inc?

Muslim investors may consider investing in Rising Biosciences Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Rising Biosciences Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Rising Biosciences Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Rising Biosciences Inc updated?

The Shariah compliance status of Rising Biosciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Rising Biosciences Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Rising Biosciences Inc?

You can check the latest Shariah compliance status of Rising Biosciences Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Rising Biosciences Inc. Stock Analysis RBII

United States Health Care Nano Cap

Rising Biosciences, Inc. engages in the research and development of alternative patient care treatments. The company is headquartered in Tustin, California. The company went IPO on 2001-06-21. The firm is focused on oral and topical cannabis and non-cannabis-based pharmaceuticals. The firm operates through three distinct business units. In addition to Oxi Thyme, the second business unit is a physician’s practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The third business unit is a research and development company focused on oral and topical pharmaceuticals. Through its subsidiaries and investment holdings, the Company is focused on the treatment of individuals in both inpatient and outpatient environments recovering from alcohol and drug addiction.

Key Statistics of Rising Biosciences Inc (RBII)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

540.08K

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

499.10

Avg. Volume

40.00K

Dividend Yield

Financial Metrics & Statements of Rising Biosciences Inc (RBII)

FAQ's for Rising Biosciences Inc (RBII)

According to Musaffa’s Shariah screening methodology, Rising Biosciences Inc (RBII) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.